This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Laura Forster: Innovator in Pharmaceutical Formulations
Introduction
Laura Forster is a prominent inventor based in Bad Homburg vor der Höhe, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for pulmonary delivery. Her innovative work has the potential to enhance the effectiveness of treatments for various respiratory conditions.
Latest Patents
Laura Forster holds a patent for a dry powder formulation designed for pulmonary delivery. This patent, titled "Dry powder formulation for pulmonary delivery and methods of use," focuses on pharmaceutical compositions that facilitate the pulmonary administration of a JAK inhibitor. The formulation includes a JAK inhibitor combined with an agglomerated lactose carrier. Additionally, the patent outlines methods for creating and utilizing this pharmaceutical composition, along with associated kits and dosage forms. She has 1 patent to her name.
Career Highlights
Laura Forster is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves research and development in the pharmaceutical sector, where she applies her expertise to create innovative solutions for patient care. Her work is instrumental in advancing therapeutic options for patients with respiratory diseases.
Collaborations
Throughout her career, Laura has collaborated with notable colleagues, including Mats Hertel and Christoph Gremmel. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in pharmaceutical formulations.
Conclusion
Laura Forster is a dedicated inventor whose work in pharmaceutical formulations is paving the way for improved treatments in respiratory health. Her contributions, particularly in the area of dry powder formulations, highlight her commitment to innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
